Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

dyskinesias And NotC. Warren Olanow

List of bibliographic references

Number of relevant bibliographic references: 21.
Ident.Authors (with country if any)Title
000246 Thomas Wichmann [États-Unis] ; Mahlon R. Delong [États-Unis] ; Jorge Guridi [Espagne] ; Jose A. Obeso [Espagne]Milestones in research on the pathophysiology of Parkinson's disease
000407 Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
000638 Iria Cabo L Pez [Espagne] ; Pedro J. García Ruiz [Espagne] ; Silvia Vázquez Fernández Del Pozo [Espagne] ; Vicenta Sánchez Bernardos [Espagne]Motor complications in Parkinson's disease: Ten year follow‐up study
000937 M. M. Wickremaratchi [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; H. R. Morris [Royaume-Uni]The effect of onset age on the clinical features of Parkinson’s disease
000A11 Giovanni Fabbrini [Italie] ; Giovanni Defazio [Italie] ; Carlo Colosimo [Italie] ; Antonio Suppa [Italie] ; Maria Bloise [Italie] ; Alfredo Berardelli [Italie]Onset and spread of dyskinesias and motor symptoms in Parkinson's disease
000B01 C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne]Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats
000C50 Anthony H. V. Schapira [Royaume-Uni]The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
000D31 Maryka Quik [États-Unis] ; Kathryn O'Leary [États-Unis] ; Caroline M. Tanner [États-Unis]Nicotine and Parkinson's disease: Implications for therapy
000F33 Charlene Hoffman Snyder [États-Unis] ; Charles H. Adler [États-Unis]The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms
000F51 J. Herzog [Allemagne] ; M. Pinsker [Allemagne] ; M. Wasner [Allemagne] ; F. Steigerwald [Allemagne] ; S. Wailke [Allemagne] ; G. Deuschl [Allemagne] ; J. Volkmann [Allemagne]Stimulation of subthalamic fibre tracts reduces dyskinesias in STN‐DBS
000F70 Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France]Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias
001309 P. Odin [Allemagne] ; C. Oehlwein [Allemagne] ; A. Storch [Allemagne] ; U. Polzer [Allemagne] ; G. Werner [Allemagne] ; R. Renner [Allemagne] ; M. Shing [Allemagne] ; A. Ludolph [Allemagne] ; P. Schüler [Allemagne]Efficacy and safety of high‐dose cabergoline in Parkinson's disease
001349 Paolo Mazzone [Italie] ; Fabrizio Stocchi [Italie] ; Salvatore Galati [Italie] ; Angelo Insola [Italie] ; Maria Grazia Altibrandi [Italie] ; Nicola Modugno [Italie] ; Domenicantonio Tropepi [Italie] ; Livia Brusa [Italie] ; Alessandro Stefani [Italie]Bilateral Implantation of Centromedian‐Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease
001427 Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis]Role of surgery in the treatment of motor complications
001450 Cheryl Waters [États-Unis]Other pharmacological treatments for motor complications and dyskinesias
001499 M. Péchevis [France] ; C. E. Clarke [Royaume-Uni] ; P. Vieregge [Allemagne] ; B. Khoshnood [France] ; C. Deschaseaux-Voinet [France] ; G. Berdeaux [France] ; M. Ziegler [France]Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study
001516 Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
001612 Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
001899 Karen Stergaard [Danemark] ; Niels Sunde [Danemark] ; Erik Dupont [Danemark]Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations
001A69 J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis]Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature
001C39 Anette Schrag [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Dyskinesias and motor fluctuations in Parkinson's disease
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024